All In MedTech

Device Trial Radar · NCT07917208

Early Feasibility Study of the Capstan Medical TMVR System

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

Apr 2027

Study completion Mar 2032

Sponsor

Lead sponsor
Capstan MedicalNot on our public-company list
Sponsor type
Industry
First posted
Nov 4, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This early feasibility study is evaluating the safety and performance of the Capstan Compass Robotic System™ for transcatheter mitral valve replacement in patients with symptomatic, moderate-to-severe or severe mitral regurgitation who are unsuitable for surgical repair or transcatheter edge-to-edge repair.

Conditions

  • Mitral Regurgitation (MR)

Interventions

  • Capstan Compass Robotic System for Transcatheter Mitral Valve ReplacementDevice

    Capstan System includes the Capstan Mitral Valve

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Safety EndpointTime frame: 30 Days
  2. Primary Performance EndpointTime frame: At the end of the procedure
  3. Primary Performance EndpointTime frame: At the end of the procedure

4 more outcomes with a free account

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Kaiser Permanente

    San Francisco, California · Not yet recruiting

  • The Christ Hospital

    Cincinnati, Ohio · Recruiting

  • Vanderbilt University Medical Center

    Nashville, Tennessee · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.